Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era
出版年份 2019 全文链接
标题
Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era
作者
关键词
-
出版物
BRITISH JOURNAL OF HAEMATOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-07-03
DOI
10.1111/bjh.16090
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Second cancers in Hodgkin's lymphoma long-term survivals: A 60-year single institutional experience with real-life cohort of 871 patients
- (2018) Katarina Petrakova et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus 131I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016
- (2018) Mazyar Shadman et al. JOURNAL OF CLINICAL ONCOLOGY
- Evolution of survivorship in lymphoma, myeloma and leukemia: Metamorphosis of the field into long term follow-up care
- (2018) Moussab Damlaj et al. BLOOD REVIEWS
- Therapy-related myeloid neoplasms: clinical perspectives
- (2018) Luana Fianchi et al. OncoTargets and Therapy
- Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts
- (2018) Clémentine Sarkozy et al. JOURNAL OF CLINICAL ONCOLOGY
- Follicular lymphoma: evolving therapeutic strategies
- (2016) B. S. Kahl et al. BLOOD
- Follicular Lymphoma: First-Line Treatment Without Chemotherapy for Follicular Lymphoma
- (2015) Patrick M. Reagan et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Therapy-related myelodysplastic syndrome
- (2015) Myrna Candelaria et al. Expert Opinion On Drug Safety
- Risk factors for second acute myeloid leukemia/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma
- (2015) C J K Lam et al. LEUKEMIA
- Long-term follow up of rates of secondary malignancy and late relapse of two trials using radioimmunotherapy consolidation following induction chemotherapy for previously untreated indolent lymphoma
- (2015) Jonathan Reiss et al. LEUKEMIA & LYMPHOMA
- Therapy-related acute myeloid leukemia in patients with lymphoma: A report of four cases and review of the literature
- (2015) DAN YANG et al. Oncology Letters
- Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience
- (2013) D. Tan et al. BLOOD
- Risk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma: The Stanford University Experience Over Three Generations of Clinical Trials
- (2013) Michael Zach Koontz et al. JOURNAL OF CLINICAL ONCOLOGY
- Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
- (2013) Mathias J Rummel et al. LANCET
- Second Cancer Risk After Chemotherapy for Hodgkin's Lymphoma: A Collaborative British Cohort Study
- (2011) Anthony J. Swerdlow et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence and prevalence of myelodysplastic syndromes: Data from the Düsseldorf MDS-registry
- (2011) Judith Neukirchen et al. LEUKEMIA RESEARCH
- Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy
- (2010) D A Carney et al. LEUKEMIA
- Bendamustine: Rebirth of an Old Drug
- (2009) Bruce D. Cheson et al. JOURNAL OF CLINICAL ONCOLOGY
- Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma
- (2008) J. W. Friedberg HAEMATOLOGICA
- Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study
- (2008) S. Sacchi et al. HAEMATOLOGICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started